exv4w4






Exhibit
4.4




EXECUTION COPY




AMENDED AND RESTATED SERIES B WARRANT AGREEMENT




Dated as of August 27, 2009




 









 





TABLE OF CONTENTS




	 	 	 	 	 
	1. ISSUANCE
	 	 	1	 
	 
	 	 	 	 
	2. DEFINITIONS AND INTERPRETATION
	 	 	1	 
	2.1   Definitions
	 	 	1	 
	2.2   Interpretations
	 	 	7	 
	 
	 	 	 	 
	3. EXERCISE OF WARRANT
	 	 	8	 
	3.1   Exercise
	 	 	8	 
	3.2   Manner of Exercise
	 	 	8	 
	3.3   Payment of Charges
	 	 	9	 
	3.4   Fractional Shares
	 	 	9	 
	 
	 	 	 	 
	4. TRANSFER, DIVISION AND COMBINATION
	 	 	9	 
	4.1   Transfer
	 	 	9	 
	4.2   Division and Combination
	 	 	10	 
	4.3   Expenses
	 	 	10	 
	4.4   Maintenance of Books
	 	 	10	 
	 
	 	 	 	 
	5. EXERCISE PRICE; ANTIDILUTION PROVISIONS
	 	 	10	 
	5.1   Exercise Price
	 	 	10	 
	5.2   Adjustments; Exceptions
	 	 	10	 
	5.3   Effect on Exercise Price of Certain Events
	 	 	12	 
	5.4   Notices
	 	 	15	 
	6. NO IMPAIRMENT
	 	 	15	 
	 
	 	 	 	 
	7. RESERVATION AND AUTHORIZATION OF COMMON STOCK; REGISTRATION WITH OR APPROVAL OF ANY
GOVERNMENTAL AUTHORITY
	 	 	16	 
	 
	 	 	 	 
	8.  NOTICE OF CORPORATE ACTIONS; TAKING OF RECORD; TRANSFER BOOKS
	 	 	16	 
	 
	 	 	 	 
	8.1   Notices of Corporate Actions
	 	 	16	 
	8.2   Taking of Record
	 	 	17	 
	8.3   Closing of Transfer Books
	 	 	17	 
	 
	 	 	 	 
	9. TRANSFER RESTRICTIONS; LEGENDS
	 	 	17	 
	 
	 	 	 	 
	9.1   Restrictions on Transfer and Entry into Shareholders Agreement and
Registration Rights Agreement
	 	 	17	 
	9.2   Legends
	 	 	17	 
	 
	 	 	 	 
	10. LOSS OR MUTILATION
	 	 	19	 
	 
	 	 	 	 
	11. OFFICE OF THE COMPANY
	 	 	19	 
	 
	 	 	 	 
	12. FINANCIAL AND BUSINESS INFORMATION
	 	 	20	 
	 
	 	 	 	 
	12.1 Deliveries
	 	 	20	 
	12.2 Financial Statements
	 	 	21	 






 









 






	 	 	 	 	 
	13. REPRESENTATIONS AND WARRANTIES
	 	 	21	 
	 
	 	 	 	 
	13.1  Holders
	 	 	21	 
	13.2  Company
	 	 	21	 
	 
	 	 	 	 
	14. MISCELLANEOUS
	 	 	22	 
	 
	 	 	 	 
	14.1 Nonwaiver
	 	 	22	 
	14.2 Notice Generally
	 	 	22	 
	14.3 Indemnification
	 	 	22	 
	14.4 Limitation of Liability; No Stockholder Rights
	 	 	23	 
	14.5 Remedies
	 	 	23	 
	14.6 Successors and Assigns
	 	 	23	 
	14.7 Amendment
	 	 	23	 
	14.8 Severability
	 	 	23	 
	14.9 Governing Law; Jurisdiction
	 	 	24	 






Exhibits




Exhibit A Form of Warrant Certificate



 









 





AMENDED AND RESTATED SERIES B WARRANT AGREEMENT




XStream Systems, Inc.




          THIS AMENDED AND RESTATED SERIES B WARRANT AGREEMENT (this “Agreement”) is entered into as of
this 27th day of August, 2009, between XStream Systems, Inc., a Delaware corporation
(the “Company”), and the Holders from time to time of the Warrants (as defined below) created
hereunder.




          WHEREAS, in connection with the issuance and sale of its Series B Units to certain investors
(the “Series B Investors”) pursuant to the terms and conditions of the Original Purchase Agreement,
the Company issued the Warrants pursuant to the terms and conditions of that certain Series B
Warrant Agreement, dated as of the Second Closing Date, by and among the Company and the Series B
Investors, as amended by that certain Amendment, dated as of the Third Closing Date (the “Original
Series B Warrant Agreement”);




          WHEREAS, in connection with the issuance and sale by the Company of shares its newly created
Series D Preferred Stock pursuant to the terms and conditions of a Series D Purchase Agreement,
dated as of the date of this Agreement (the “Series D Purchase Agreement”), by and among the
Company and the investors set forth therein, and as a condition to the closing thereunder, at least
a majority of the Holders have agreed to amend the terms and provisions of the Original Series B
Warrant Agreement as set forth herein;




          NOW, THEREFORE, in consideration of the foregoing, the parties hereto hereby agree as follows:




1. ISSUANCE




          The Company issued and delivered a certificate or certificates substantially in the form of
Exhibit A hereto (the “Warrant Certificates”) evidencing warrants (the “Warrants”) to
purchase Four Million Eight Hundred Fifty Seven Thousand Three Hundred Eighty One (4,857,381)
shares of Common Stock at the per share exercise price specified in Section 5 on the terms
and conditions set forth in this Agreement. Each Warrant Certificate was dated Original Issue Date
and an officer signed each Warrant Certificate by manual or facsimile signature. All Warrants are
identical as to terms and conditions and Expiration Date, except as to the number of shares of
Common Stock for which they may be exercised.




2. DEFINITIONS AND INTERPRETATION




     2.1 Definitions. As used in this Agreement, the following terms have the respective meanings set forth below:



          “Agreed Rate” means the base rate on corporate loans posted by at least 75% of the thirty
largest banks in the United States, as reported in the Money Rates section of The Wall Street
Journal.




          “Agreement” shall have the meaning set forth in the preamble.




 









 








          “Amended Series B Designation” means the Amended Certificate of Designation relating to the
Series B Preferred Stock filed with the Secretary of State of Delaware in connection with the
closing under the Series D Purchase Agreement, as may be amended from time to time.




          “Amended Series C Designation” means the Amended Certificate of Designation relating to the
Series C Preferred Stock filed with the Secretary of State of Delaware in connection with the
closing under the Series D Purchase Agreement, as may be amended from time to time.




          “Board” means the board of directors of the Company.




          “Book Value” per share of Common Stock as of a date specified herein means the consolidated
book value of the Company and its Subsidiaries as of such date divided by the number of shares of
Common Stock Outstanding on such date. Such book value shall be determined in accordance with
GAAP.




          “Business Day” means any day that is not a Saturday, Sunday or other day on which commercial
banks in New York City or the State of Florida are authorized or required by law to close.




          “By-laws” means the Amended and Restated By-laws of the Company as currently in effect on the
date of this Agreement.




          “Catalyst” means Catalyst Capital Investments LLC, a Delaware limited liability company.




          “Catalyst Letter Agreements” means, collectively, (a) that certain letter agreement dated as
of May 31, 2006 between Catalyst and the Company regarding the introduction of prospective
suppliers, (b) that certain letter agreement dated as of May 31, 2006 between Catalyst and the
Company regarding the introduction of prospective customers, (c) that certain Consulting Agreement
dated as of May 1, 2007 between Catalyst and the Company and (d) such amendments to the foregoing
or other agreements between Catalyst and the Company as may be approved by a majority of the Board
(including at least one of the Investor Directors).




          “Certificate of Incorporation” means the Certificate of Incorporation of the Company, as
amended to date (after giving effect to the filing of the Second Amended Series A Designation, the
Amended Series B Designation, the Amended Series C Designation and the Series D Certificate of
Designation with the Delaware Secretary of State), and as may be further amended or restated from
time to time.




          “Common Deemed Outstanding” means, at any given time, the number of shares of Common Stock
Outstanding at such time, plus the number of shares of Common Stock deemed to be outstanding
pursuant to Sections 5.3(a) and 5.3(b) whether or not the Options or Convertible
Securities are actually convertible or exercisable at such time.




2









 








          “Common Equivalent Basis” means, as of the date of such determination, the number of shares of
Common Stock that each holder of Preferred Stock would be entitled to receive upon conversion of
such holder’s Preferred Stock into Common Stock.




          “Common Stock” means (except where the context otherwise indicates) the common stock of the
Company, par value $.0001 per share, as constituted on the Original Issue Date, and any capital
stock into which such Common Stock may thereafter be changed, and shall also include (i) capital
stock of the Company of any other class (regardless of how denominated) issued to the holders of
shares of any Common Stock upon any reclassification thereof which is also not preferred as to
dividends or liquidation over any other class of stock of the Company and which is not subject to
redemption and (ii) shares of common stock of any successor or acquiring corporation received by or
distributed to the holders of Common Stock of the Company under the circumstances contemplated by
Section 5.3(j).




          “Company” shall have the meaning set forth in the preamble.




          “Company Default” means (a) the breach of any warranty or the inaccuracy at the time when made
of any representation made by the Company herein or (b) the failure by the Company to comply with
any covenant of the Company contained herein.




          “Conversion Common Shares” means (i) the Common Stock issued or issuable upon conversion of
the Preferred Stock and (ii) any Common Stock issued or issuable with respect to the securities
referred to in clause (i) above by way of stock dividend or stock split or in connection with a
combination of shares, recapitalization, merger, consolidation or other reincorporation. As to any
particular Conversion Common Shares, such shares shall cease to be Conversion Common Shares when
they have been (x) effectively registered under the Securities Act and disposed of in accordance
with the registration statement covering them, (y) distributed to the public through a broker,
dealer or market maker pursuant to Rule 144 under the Securities Act or any comparable rule under
any similar federal statute then in force or (z) repurchased by the Company.




          “Convertible Securities” means any stock or securities directly or indirectly convertible into
or exchangeable for Common Stock.




          “Current Market Price” means as of any specified date the average of the daily market prices
of the Common Stock of the Company for the twenty (20) consecutive Business Days immediately
preceding such date. The “daily market price” for each such Business Day shall be: (i) if the
Common Stock is then listed on a national securities exchange, the last sale price, regular way, on
such day on the principal stock exchange on which such Common Stock is then listed or admitted to
trading, or, if no such sale takes place on such day, the average of the closing bid and asked
prices for the Common Stock on such day as reported on such stock exchange or (ii) if the Common
Stock is not then listed or admitted to trading on any national securities exchange but is traded
over-the-counter, the average of the closing bid and asked prices for the Common Stock as reported
on NASDAQ or the Electronic Bulletin Board or in the National Daily Quotation Sheets, as
applicable.




          “Designated Office” shall have the meaning set forth in Section 11.




3









 








          “Exercise Date” shall have the meaning set forth in Section 3.2(a).




          “Exercise Notice” shall have the meaning set forth in Section 3.2(a).




          “Exercise Price” shall have the meaning specified in Section 5.1.




          “Expiration Date” means the tenth (10th) anniversary of the Original Issue Date.




          “First Closing Date” means March 14, 2007.




          “GAAP” means generally accepted accounting principles in the United States of America as from
time to time in effect.




          “Holder” means the Person in whose name a Warrant is registered on the books of the Company
maintained for such purpose.




          “Investor Directors” means the members of the Board designated by the Investors (as defined in
the Shareholders Agreement) pursuant to the terms of the Shareholders Agreement.




          “Lien” means any mortgage or deed of trust, pledge, hypothecation, assignment, deposit
arrangement, lien, charge, claim, security interest, easement or encumbrance, or preference,
priority or other security agreement or preferential arrangement of any kind or nature whatsoever
(including any lease or title retention agreement, any financing lease having substantially the
same economic effect as any of the foregoing, and the filing of, or agreement to give, any
financing statement perfecting a security interest under the Uniform Commercial Code or comparable
law of any jurisdiction).




          “Majority Warrant Holders”, with respect to a given determination, means the Holders of
Warrants exercisable for more than fifty percent (50%) of the aggregate number of shares of Warrant
Stock issuable upon the exercise of all Warrants outstanding and unexercised at the time of such
determination.




          “Material Adverse Effect” means an adverse effect of $100,000 or more on the condition
(financial or otherwise), operating results, business, prospects, assets, operations, employee
relations or customer or supplier relations of the Company and its Subsidiaries, taken as a whole;
provided, however, that no change, circumstance, effect, event or fact shall be deemed to be a
Material Adverse Effect to the extent that it is caused by the execution or public announcement of
the Original Purchase Agreement or the Series D Purchase Agreement or the transactions contemplated
hereby.




          “NASDAQ” means the NASDAQ quotation system, or any successor reporting system.




          “Option Plan” means the Company’s Amended and Restated 2004 Stock Option Incentive Plan, as
amended by that certain First Amendment, dated as of July 23, 2009.




4









 








          “Options” means any agreements, rights, warrants or options to subscribe for or purchase
Common Stock or Convertible Securities.




          “Organic Change” shall have the meaning set forth in Section 5.3(j).




          “Original Issue Date” means the Second Closing Date.




          “Original Purchase Agreement” means the Series A Preferred Stock Purchase Agreement, dated as
of the First Closing Date, as amended by a First Amendment dated as of the Second Closing Date, as
further amended by a Second Amendment dated as of the Third Closing Date, as further amended by a
Third Amendment dated as of October 16, 2008 and as further amended by a Fourth Amendment dated as
of February 26, 2009.




          “Original Series B Warrant Agreement” shall have the meaning set forth in the recitals.




          “Original Warrants” means the Warrants originally issued by the Company to the Series B
Investors on the Original Issue Date or the Third Closing Date, as the case may be.




          “Outstanding” means, when used with reference to Common Stock, at any date as of which the
number of shares thereof is to be determined, all issued shares of Common Stock, except shares then
owned or held by or for the account of the Company or any Subsidiary thereof, and shall include all
shares issuable in respect of outstanding scrip or any certificates representing fractional
interests in shares of Common Stock.




          “Permitted Issuances” means the issuance and sale of the Preferred Stock expressly
contemplated by the Original Purchase Agreement and the Series D Purchase Agreement.




          “Person” means any individual, sole proprietorship, partnership, limited liability company,
joint venture, trust, incorporated organization, association, corporation, institution, public
benefit corporation, entity or government (whether federal, state, county, city, municipal or
otherwise, including any instrumentality, division, agency, body or department thereof).




          “Preferred Stock” means the Series A Preferred Stock, the Series B Preferred Stock, the Series
C Preferred Stock and the Series D Preferred Stock.




          “Qualified IPO” means the receipt by the Company of total gross offering proceeds of at least
$50,000,000 from the sale to the public of shares of Common Stock at a gross price per share not
less than $16 (as adjusted to reflect stock splits, stock dividends, stock combinations,
recapitalizations and like occurrences) pursuant to a firm commitment underwritten offering under
an effective registration statement under the Securities Act, or any comparable statement under any
similar federal statute then in force.




          “Registration Rights Agreement” means the Amended and Restated Registration Rights Agreement,
dated as of the date of this Agreement, as amended, by and among the Company and the Persons named
therein (as the same may be amended, modified, restated or replaced).




5









 








          “Second Amended Series A Designation” means the Second Amended Certificate of Designation
relating to the Series A Preferred Stock filed with the Secretary of State of Delaware in
connection with the closing under the Series D Purchase Agreement, as may be amended from time to
time.




          “Second Closing Date” means December 19, 2007.




          “Securities Act” means the Securities Act of 1933, as amended.




          “Series A Preferred Stock” means the Series A Redeemable Convertible Preferred Stock, $.0001
par value per share of the Company.




          “Series B Investors” shall have the meaning set forth in the recitals.




          “Series B Preferred Stock” means the Series B Redeemable Convertible Preferred Stock, $.0001
par value per share of the Company.




          “Series B Unit” means one share of Series B Preferred Share and five (5) Warrants.




          “Series C Preferred Stock” means the Series C Redeemable Convertible Preferred Stock, $.0001
par value per share of the Company.




          “Series C Warrants” means the warrants to purchase Common Stock of the Company issuable
pursuant to that certain Amended and Restated Series C Warrant Agreement, dated as of the date of
this Agreement, by and among the Company and the holders thereof.




          “Series D Certificate of Designation” means the Certificate of Designation relating to the
Series D Preferred Stock filed with the Secretary of State of Delaware in connection with the
closing under the Series D Purchase Agreement, as may be amended from time to time.




          “Series D Preferred Stock” means the Series D Redeemable Convertible Preferred Stock, $.0001
par value per share of the Company.




          “Series D Purchase Agreement” shall have the meaning set forth in the recitals.




          “Series D Warrants” means the warrants to purchase Common Stock of the Company issuable
pursuant to the Series D Warrant Agreement, dated as of the date of this Agreement, by and among
the Company and the holders thereof.




          “Shareholders Agreement” means the Second Amended and Restated Securityholders’ Agreement,
dated as of the date of this Agreement, by and among the Company and the Persons named therein (as
the same may be amended, modified, restated or replaced).




          “Subsidiary” means any corporation or association (a) more than 50% (by number of votes) of
the voting stock of which is at the time owned by the Company, by one or more Subsidiaries, or by
the Company and one or more Subsidiaries, (b) any other business




6









 







entity in which the Company, one or more Subsidiaries, or the Company and one or more
Subsidiaries own more than a 50% interest either in the profits or capital of such business entity
or (c) whose net earnings, or portions thereof, are consolidated with the net earnings of the
Company and are recorded on the books of the Company for financial reporting purposes in accordance
with GAAP.




          “Third Closing Date” means May 30, 2008.




          “Transfer” means any transfer, sale, assignment, option, pledge, hypothecation or other direct
or indirect disposal of or encumbrance of any Warrant or of any interest therein, either by
operation of law or otherwise.




          “Warrant Certificates” shall have the meaning set forth in Section 1.




          “Warrant Price” means an amount equal to the number of shares of Warrant Stock being purchased
multiplied by the Exercise Price.




          “Warrants” shall have the meaning set forth in Section 1.




          “Warrant Stock” means the shares of Common Stock issued, issuable or both (as the context may
require) upon the exercise of Warrants.




     2.2 Interpretations. For purposes of this Agreement:



          (a) The words “include,” “includes” and “including” shall be deemed to be followed by the
words “without limitation;” the word “or” is not exclusive; and the words “herein,” “hereof,”
“hereby,” “hereto” and “hereunder” refer to this Agreement as a whole.




          (b) Unless the context otherwise requires, references herein: (1) to Sections mean the
Sections of this Agreement; (2) to an agreement, instrument or other document means such agreement,
instrument or other document as amended, supplemented and modified from time to time to the extent
permitted by the provisions thereof and by this Agreement; and (3) to a statute means such statute
as amended from time to time and includes any successor legislation thereto and any regulations
promulgated thereunder.




          (c) Headings of Sections are inserted for convenience of reference only and shall not be
deemed a part of or to affect the meaning or interpretation of this Agreement.




          (d) Relative to the determination of any period of time, “from” means “from and including,”
“to” means “to but excluding” and “through” means “through and including.”




          (e) Words used in the singular include the plural and words in the plural include the
singular.




          (f) Each of the parties to this Agreement has had the benefit of counsel in the negotiation,
preparation and execution of this Agreement. This Agreement shall be construed
without regard to any presumption or rule requiring construction or interpretation against the
party drafting an instrument or causing any instrument to be drafted.




7









 








3. EXERCISE OF WARRANT




     3.1 Exercise.



          Each Warrant shall initially entitle the Holder thereof to purchase shares of Common Stock at
a per share exercise price equal to the Exercise Price (subject to adjustment as provided in
Section 5), in each case as provided herein and all on the terms and conditions and
pursuant to the provisions hereinafter set forth.




     3.2 Manner of Exercise.



          (a) From and after the Original Issue Date and until 5:00 P.M., New York, New York time, on
the Expiration Date, a Holder of a Warrant may from time to time exercise such Warrant, on any
Business Day, for all or any part of the number of shares of Common Stock purchasable thereunder.
In order to exercise a Warrant, in whole or in part, the Holder shall (i) deliver to the Company at
the Designated Office a written notice of the Holder’s election to exercise such Warrant (an
“Exercise Notice”), which Exercise Notice shall be irrevocable (except as otherwise provided in
Section 3.2(e)) and specify the number of shares of Common Stock being purchased, together
with the Warrant, (ii) pay to the Company the Warrant Price (the date on which both such delivery
and payment shall have first taken place being hereinafter sometimes referred to as the “Exercise
Date”) and (iii) if such Holder has not already done so, become a party to each of the Shareholders
Agreement and the Registration Rights Agreement by completing and executing a signature page
thereof. Such Exercise Notice shall be in the form of the subscription form appearing as Annex A
to Exhibit A, duly executed by the Holder or its duly authorized agent or attorney.




          (b) Upon receipt of such Exercise Notice, Warrant and payment and any other materials required
to be provided under Section 3.2(a), the Company shall, as promptly as practicable, and in
any event within five (5) Business Days thereafter, execute (or cause to be executed) and deliver
(or cause to be delivered) to the Holder a certificate or certificates representing the aggregate
number of full shares of Common Stock issuable upon such exercise, together with either any
fraction of a share or cash in lieu of any fraction of a share, as hereafter provided in
Section 3.4. The stock certificate or certificates so delivered shall be, to the extent
possible, in such denomination or denominations as the exercising Holder shall reasonably request
in the Exercise Notice and shall be registered in the name of the Holder or the name of its
nominee. A Warrant shall be deemed to have been exercised and such certificate or certificates
shall be deemed to have been issued, and the Holder or any other Person so designated to be named
therein shall be deemed to have become a Holder of record of such shares for all purposes, as of
the Exercise Date.




          (c) Payment of the Warrant Price may be made by check payable to the order of the Company or,
at the option of the Holder, by wire transfer of funds to an account designated by the Company for
such purpose.




          (d) If a Warrant shall have been exercised in part, the Company shall, at the time of delivery
of the certificate or certificates representing the shares of Common Stock being issued, deliver to
the Holder a new Warrant evidencing the rights of the Holder to purchase the




8









 







number of unexercised
shares called for by such Warrant. Such new Warrant shall in all other respects be identical with
the original Warrant and subject to the terms of this Agreement.




          (e) Notwithstanding the foregoing provisions of this Section 3.2, a Holder (i) may
expressly condition the effectiveness of any exercise of a Warrant upon the simultaneous closing of
the sale, in an offering registered under the Securities Act or pursuant to the exercise of any
drag-along or co-sale rights under the Shareholders Agreement, of the shares of Common Stock as to
which the conditional exercise is being made and (ii) may revoke any such conditional exercise in
the event that the closing of such sale shall not occur. In the event that such simultaneous
exercise and sale shall occur, the Company shall cooperate with such Holder and any third parties
involved in such sale to facilitate the issuance and sale of the shares of Common Stock involved.




     3.3 Payment of Charges.



          All shares of Common Stock issuable upon the exercise of a Warrant pursuant to the terms
hereof shall be validly issued, fully paid and nonassessable, issued without violation of any
preemptive rights and free and clear of all Liens (other than, to the extent permitted by
Section 9, any created by actions of the Holder). The Company shall pay all expenses in
connection with the issue or delivery thereof, unless such charge is imposed by law upon the
Holder, in which case such charge shall be paid by the Holder and the Company shall reimburse the
Holder therefor.



     3.4 Fractional Shares.



          The Company shall not be required to issue a fractional share of Common Stock upon exercise of
any Warrant. As to any fraction of a share that the Holder of one or more Warrants, the rights
under which are exercised in the same transaction, would otherwise be entitled to purchase upon
such exercise, the Company shall, at its option, issue upon exercise either (i) the fractional
share of Common Stock to which the Holder of one or more Warrants would otherwise be entitled or
(ii) a cash adjustment in respect of such final fraction in an amount equal to the same fraction of
(A) the Current Market Price of one share of Common Stock on the Exercise Date, if the Common Stock
is then publicly traded or (B) the Book Value per share of Common Stock based on the most recent
available consolidated balance sheet of the Company, if the Common Stock is not then publicly
traded.



4. TRANSFER, DIVISION AND COMBINATION




     4.1 Transfer.



          Subject to compliance with Section 9 and the Shareholders Agreement, each transfer of
a Warrant and all rights hereunder, in whole or in part, shall be registered on the books of the
Company to be maintained for such purpose, upon surrender of a Warrant at the Designated Office,
together with a written assignment of such Warrant in the form of Annex B to Exhibit A
hereto, duly executed by the Holder or its agent or attorney. Upon such surrender and delivery,
(i) the Company shall, subject to Section 9, execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees and in the denominations specified in such instrument of
assignment, and shall issue to the assignor a new Warrant evidencing the portion of



9









 






the original
Warrant not so assigned and the original Warrant shall promptly be cancelled and (ii) if not
already a party to the Shareholders Agreement and the Registration Rights Agreement, each assignee
shall become a party to each of the Shareholders Agreement and the Registration Rights Agreement by
completing and executing a joinder agreement thereto. A Warrant, if properly assigned in
compliance with Section 9 and the Shareholders Agreement, may be exercised by the new
Holder for the purchase of shares of Common Stock without having a new Warrant issued.




     4.2 Division and Combination.



          Subject to compliance with the applicable provisions of this Agreement, a Warrant may be
divided or combined with other Warrants upon presentation thereof at the Designated Office,
together with a written notice specifying the names and denominations in which new Warrants are to
be issued, signed by the Holder or its agent or attorney. Subject to compliance with the
applicable provisions of this Agreement and the Shareholders Agreement as to any transfer which may
be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such
notice.




     4.3 Expenses.



          The Company shall prepare, issue and deliver at its own expense any new Warrant or Warrants
required to be issued under this Section 4.




     4.4 Maintenance of Books.



          The Company agrees to maintain, at the Designated Office, books for the registration and
transfer of the Warrants.




5. EXERCISE PRICE; ANTIDILUTION PROVISIONS




     5.1 Exercise Price.



          The initial exercise price shall be $3.00 per share of Common Stock (subject to adjustment
from time to time as provided in this Section 5) (as so adjusted, the “Exercise Price”).




     5.2 Adjustments; Exceptions.



          (a) If and whenever on or after the Original Issue Date the Company issues or sells or, in
accordance with this Section 5, is deemed to have issued or sold, any shares of its Common
Stock for a consideration per share less than the Exercise Price in effect immediately prior to the
time of such issuance, then immediately upon such issuance or sale or deemed issuance or sale the
Exercise Price shall be reduced to the exercise price determined by dividing (i) the sum of
(1) the product derived by multiplying the Exercise Price in effect immediately prior to such
issuance or sale by the number of shares of Common Deemed Outstanding immediately prior to such
issuance or sale, plus (2) the consideration, if any, received by the



10









 






Company upon such issuance or
sale, by (ii) the number of shares of Common Deemed Outstanding immediately after such
issue or sale.




          (b) Notwithstanding the foregoing, there shall be no adjustment in the Exercise Price as a
result of any issuance or sale (or deemed issuance or sale) of:





          (i) shares of Common Stock issued upon conversion of the Preferred Stock;




          (ii) shares of Common Stock issued upon the exercise of the Warrants, the Series C
Warrants or the Series D Warrants;




          (iii) shares of Common Stock issued upon the exercise of Options or other Convertible
Securities outstanding as of the First Closing Date;




          (iv) securities issued pursuant to a Board-approved (including at least one of the
Investor Directors) bona fide acquisition of an entity by merger, purchase of substantially
all of the assets or other reorganization;




          (v) shares of Common Stock issued to Catalyst pursuant to the Options granted under the
Catalyst Letter Agreements;




          (vi) shares of Common Stock or other securities issued as a dividend or distribution
on, or in connection with a split of or recapitalization of, any of the capital stock of the
Company;




          (vii) up to an aggregate of Eight Hundred Thousand (800,000) shares (or such greater or
lesser number of shares as may be approved by a majority of the Board (including at least
one of the Investor Directors)) of Common Stock reserved for issuance per year pursuant to
the Option Plan (subject to adjustment in the event of stock splits, stock dividends, stock
combinations, recapitalizations and like occurrences) and shares of Common Stock reserved
for issuance pursuant to the Option Plan in lieu of the
repayment of certain salary deferrals as approved by a majority of the Board (including
at least one of the Investor Directors), which foregoing shares may be subject to Options or
restricted stock awards granted under the Option Plan; provided that any Options that expire
or terminate unexercised or any restricted stock awards that are repurchased by the Company
pursuant to the terms of such award shall not be counted toward the maximum number set forth
in this subparagraph (vii) unless and until such shares are subject to new restricted stock
awards (or new Options) pursuant to the terms of the Option Plan;




          (viii) shares of Common Stock issued or issuable (including Options to acquire such
 shares of Common Stock) to suppliers or third-party service providers in connection with the
provision of goods or services pursuant to transactions in the ordinary course of business
and approved by a majority of the Board, including at least one of the Investor Directors;




          (ix) shares of Common Stock issued or issuable in connection with bona-fide sponsored
research, collaboration, technology license, development, OEM,



11









 







marketing or other similar agreements or strategic partnerships or joint ventures entered into in the ordinary course
of business and approved by a majority of the Board, including at least one of the Investor
Directors (and by at least a majority of the shares of Preferred Stock and Conversion Common
Shares, voting as a single class on a Common Equivalent Basis, then outstanding, if required
pursuant to Section 3(c) of the Amended Series B Designation);




          (x) securities issued in connection with a Qualified IPO;




          (xi) Permitted Issuances; or




          (xii) Options (covering up to an aggregate of Three Hundred Thirty Thousand (330,000)
shares of Common Stock) issued in substitution for outstanding Options;


provided that the aggregate number of shares of Common issued or issuable pursuant to clauses
(viii) and (ix) above shall not exceed Three Hundred Fifty Thousand (350,000) shares (or such
greater or lesser number of shares as may be approved by a majority of the Board (including at
least one of the Investor Directors)) in any twelve-month period.




     5.3 Effect on Exercise Price of Certain Events.



          For purposes of determining any adjustments to the Exercise Price under this Section
5, the following shall be applicable:




          (a) Issuance of Options. If the Company in any manner grants, issues or sells any
Options (other than any Options permitted by Section 5.2(b)) and the price per share for
which Common Stock is issuable upon the exercise of such Options, or upon conversion or exchange of
any Convertible Securities issuable upon exercise of such Options, is less than the Exercise Price
in effect immediately prior to the time of the granting, issuance or sale of such
Options, then the total maximum number of shares of Common Stock issuable upon the exercise of
such Options or upon conversion or exchange of the total maximum amount of such Convertible
Securities issuable upon the exercise of such Options shall be deemed to be outstanding and to have
been issued and sold by the Company at the time of the granting, issuance or sale of such Options
for such price per share. For purposes of this paragraph, the “price per share for which Common
Stock is issuable” shall be determined by dividing (i) the sum of (1) the total amount, if any,
received or receivable by the Company as consideration for the granting, issuance or sale of such
Options, plus (2) the minimum aggregate amount of additional consideration payable to the Company
upon exercise of all such Options, plus (3) in the case of such Options which relate to Convertible
Securities, the minimum aggregate amount of additional consideration, if any, payable to the
Company upon the issuance or sale of such Convertible Securities and the conversion or exchange
thereof, by (ii) the total maximum number of shares of Common Stock issuable upon the exercise of
such Options or upon the conversion or exchange of all such Convertible Securities issuable upon
the exercise of such Options. No further adjustment of the Exercise Price shall be made when
Convertible Securities are actually issued upon the exercise of such Options or when Common Stock
actually issued upon the exercise of such Options or the conversion or exchange of such Convertible
Securities.




12









 








          (b) Issuance of Convertible Securities. If the Company in any manner issues or sells
any Convertible Securities and the price per share for which Common Stock is issuable upon
conversion or exchange thereof is less than the Exercise Price in effect immediately prior to the
time of such issuance or sale, then the maximum number of shares of Common Stock issuable upon
conversion or exchange of such Convertible Securities shall be deemed to be outstanding and to have
been issued and sold by the Company at the time of the issuance or sale of such Convertible
Securities for such price per share. For the purposes of this paragraph, the “price per share for
which Common Stock is issuable” shall be determined by dividing (i) the sum of (1) the total amount
received or receivable by the Company as consideration for the issuance or sale of such Convertible
Securities, plus (2) the minimum aggregate amount of additional consideration, if any, payable to
the Company upon the conversion or exchange thereof, by (B) the total maximum number of shares of
Common Stock issuable upon the conversion or exchange of all such Convertible Securities. No
further adjustment of the Exercise Price shall be made when Common Stock is actually issued upon
the conversion or exchange of such Convertible Securities, and if any such issuance or sale of such
Convertible Securities is made upon exercise of any Options for which adjustments of the Exercise
Price had been or are to be made pursuant to other provisions of this Section 5, no further
adjustment of the Exercise Price shall be made by reason of such issue or sale.




          (c) Change in Option Price or Conversion Rate. If the purchase price provided for in
any Options, the additional consideration, if any, payable upon the conversion or exchange of any
Convertible Securities or the rate at which any Convertible Securities are convertible into or
exchangeable for Common Stock changes at any time, the Exercise Price in effect at the time of such
change shall be immediately adjusted to the Exercise Price that would have been in effect at such
time had such Options or Convertible Securities still outstanding provided for such changed
purchase price, additional consideration or conversion rate, as the case may be, at the time
initially granted, issued or sold; provided that if such adjustment of the Exercise Price would
result in an increase in the Exercise Price then in effect, the Company will promptly give all
Holders written notice of such increase. For purposes of this subsection (c), if
the terms of any Option or Convertible Security that was outstanding as of the Original Issue
Date are changed in the manner described in the immediately preceding sentence, then such Option or
Convertible Security and the Common Stock deemed issuable upon exercise, conversion or exchange
thereof shall be deemed to have been issued as of the date of such change; provided that no such
change shall at any time cause the Exercise Price hereunder to be increased.




          (d) Treatment of Expired Options and Unexercised Convertible Securities. Upon the
expiration of any Option or the termination of any right to convert or exchange any Convertible
Security without the exercise of any such Option or right, the Exercise Price then in effect
hereunder shall be adjusted immediately to the Exercise Price that would have been in effect at the
time of such expiration or termination had such Option or Convertible Security, to the extent
outstanding immediately prior to such expiration or termination, never been issued; provided that
if such expiration or termination would result in an increase in the Exercise Price then in effect,
the Company will promptly give all Holders of Warrants written notice of such increase. For
purposes of this subsection (d), the expiration or termination of any Option or Convertible
Security that was outstanding as of the Original Issue Date shall not cause the Exercise Price
hereunder to be adjusted unless, and only to the extent that, a change in the terms



13









 






of such Option
or Convertible Security caused it to be deemed to have been issued after the Original Issue Date.




          (e) Calculation of Consideration Received. If any Common Stock, Option or Convertible
Security is issued or sold or deemed to have been issued or sold for cash, the consideration
received therefor shall be deemed to be the amount received by the Company therefor (net of
discounts, commissions and related expenses). If any Common Stock, Option or Convertible Security
is issued or sold for a consideration other than cash, the amount of the consideration other than
cash received by the Company shall be the fair market value of such consideration as determined in
good faith by the Board. If any Common Stock, Option or Convertible Security is issued to the
owners of the non-surviving entity in connection with any merger in which the Company is the
surviving corporation, the amount of consideration therefor shall be deemed to be the fair value of
such portion of the net assets and business of the non-surviving entity as is attributable to such
Common Stock, Option or Convertible Security, as the case may be. The fair value of any
consideration other than cash and securities shall be the fair market value as determined in good
faith by the Board.




          (f) Integrated Transactions. In case any Option is issued in connection with the
issuance or sale of other securities of the Company, together comprising one integrated transaction
in which no specific exercise price is allocated to such Option by the parties thereto, the Option
shall be deemed to have been issued at an exercise price of $0.01.




          (g) Treasury Shares. The number of shares of Common Stock Outstanding at any given
time shall not include shares owned or held by or for the account of the Company, and the
disposition of any shares so owned or held shall be considered an issuance or sale of such shares.




          (h) Record Date. If the Company takes a record of the holders of Common Stock for the
purpose of entitling them (i) to receive a dividend or other distribution payable in
Common Stock, Options or in Convertible Securities or (ii) to subscribe for or purchase Common
Stock, Options or Convertible Securities, then such record date shall be deemed to be the date of
the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the
declaration of such dividend or upon the making of such other distribution or the date of the
granting of such right of subscription or purchase, as the case may be.




          (i) Subdivisions or Combinations of Common Stock. If the Company at any time
subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes
of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in
effect immediately prior to such subdivision shall be reduced proportionately, and if the Company
at any time combines (by reverse stock split or otherwise) one or more classes of its outstanding
shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately
prior to such combination shall be increased proportionately.




          (j) Recapitalization, Reorganization, Reclassification, Consolidation, Merger or Sale.
Any recapitalization, reorganization, reclassification, consolidation, merger, sale of all or
substantially all of the Company’s assets or other transaction, in each case which is effected in
such a manner that the holders of Common Stock are entitled to receive (either directly or upon



14









 






subsequent liquidation) stock, securities or assets with respect to or in exchange for Common
Stock, is referred to herein as an “Organic Change.” Prior to the consummation of any Organic
Change, the Company shall make appropriate provisions (in form and substance reasonably
satisfactory to the Majority Warrant Holders) to insure that each of the Holders shall thereafter
have the right to acquire and receive, in lieu of or in addition to (as the case may be) the shares
of Common Stock immediately theretofore acquirable and receivable upon the exercise of such
Holder’s Warrant, such shares of stock, securities or assets as such Holder would have received in
connection with such Organic Change if such Holder had exercised its Warrant immediately prior to
such Organic Change. In each such case, the Company shall also make appropriate provisions (in
form and substance reasonably satisfactory to the Majority Warrant Holders) to insure that the
provisions of this Section 5 shall thereafter be applicable to the securities issued upon
exercise of the Warrants (including, in the case of any such consolidation, merger or sale in which
the successor entity or purchasing entity is other than the Company and the value for the Common
Stock reflected by the terms of such consolidation, merger or sale is less than the Exercise Price
in effect immediately prior to such consolidation, merger or sale, an immediate adjustment of the
Exercise Price to the value for the Common Stock so reflected and a corresponding immediate
adjustment in the number of shares of Common Stock acquirable and receivable upon the exercise of
the Warrants). The Company shall not effect any such Organic Change, unless prior to the
consummation thereof, the successor entity (if other than the Company) resulting from consolidation
or merger or the entity purchasing such assets assumes by written instrument (in form and substance
satisfactory to the Majority Warrant Holders) the obligation to deliver to each such Holder such
shares of stock, securities or assets as, in accordance with the foregoing provisions, such holder
may be entitled to acquire.




          (k) Certain Other Events. If any event occurs of the type contemplated by the
provisions of this Section 5 but not expressly provided for by such provisions (including,
without limitation, the granting of stock appreciation rights, phantom stock rights or other rights
with equity features), then the Board shall make an appropriate adjustment in the Exercise Price so
as to protect the rights of the Holders of Warrants; provided that no such adjustment shall
increase
the Exercise Price as otherwise determined pursuant to this Section 5 or decrease the
number of shares of Common Stock issuable upon exercise of each Warrant.




     5.4 Notices.



          Immediately upon any adjustment of the Exercise Price, the Company shall give written notice
thereof to all Holders, setting forth in reasonable detail and certifying the calculation of such
adjustment.




6. NO IMPAIRMENT




          The Company shall not by any action, including amending its charter documents or through any
reorganization, reclassification, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other similar voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Agreement, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of the Holder of any Warrant against impairment. Without
limiting the generality of the foregoing, the Company shall take all such




15









 







action as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock upon the exercise of the Warrants, free and clear of all Liens
(other than, to the extent permitted by Section 9, any created by actions of the Holder),
and shall use its commercially reasonable efforts to obtain all such authorizations, exemptions or
consents from any public regulatory body having jurisdiction thereof as may be necessary to enable
the Company to perform its obligations under this Agreement.




7. RESERVATION AND AUTHORIZATION OF COMMON STOCK; REGISTRATION WITH OR APPROVAL OF ANY GOVERNMENTAL
AUTHORITY




          From and after the Original Issue Date, the Company shall at all times reserve and keep
available for issuance upon the exercise of the Warrants such number of its authorized but unissued
shares of Common Stock as will be sufficient to permit the exercise in full of all outstanding
Warrants. All shares of Common Stock issuable pursuant to the terms hereof, when issued upon
exercise of Warrants with payment therefor in accordance with the terms hereof, shall be duly and
validly issued and fully paid and nonassessable, not subject to preemptive rights and shall be free
and clear of all Liens (other than, to the extent permitted by Section 9, any created by
actions of the Holder). Before taking any action that would result in an adjustment in the number
of shares of Common Stock for which the Warrants are exercisable, the Company shall obtain all such
authorizations or exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction over such action. If any shares of Common Stock
required to be reserved for issuance upon exercise of Warrants require registration or
qualification with any governmental authority under any federal or state law (other than under the
Securities Act or any state securities law) before such shares may be so issued, the Company will
in good faith and as expeditiously as possible and at its expense endeavor to cause such shares to
be duly registered.




8. NOTICE OF CORPORATE ACTIONS; TAKING OF RECORD; TRANSFER BOOKS




     8.1 Notices of Corporate Actions.



          In the event of: (a) any taking by the Company of a record of the holders of any class of
securities for the purpose of determining the holders thereof who are entitled to receive any
dividend or distribution, (other than cash dividends payable upon shares of Preferred Stock of the
Company), or any right to subscribe for, purchase or otherwise acquire any shares of capital stock
of any class or any other securities, (b) any capital reorganization of the Company, any
reclassification or recapitalization of the capital stock of the Company or any consolidation or
merger involving the Company and any other Person or any transfer or other disposition of all or
substantially all the assets of the Company to another Person, (c) any voluntary or involuntary
dissolution, liquidation or winding-up of the Company, (d) any amendment of the Certificate of
Incorporation of the Company or (e) any registration or public offering of Common Stock, the
Company shall mail to each Holder of a Warrant in accordance with the provisions of Section
14.2 a notice specifying (i) in the case of a dividend or distribution, the date or expected
date on which any such record is to be taken for the purpose of such dividend, distribution or
right, and the amount and character of such dividend, distribution or right, (ii) in the case of a




16









 







reorganization, reclassification, recapitalization, consolidation, merger, transfer, disposition,
dissolution, liquidation or winding-up, the date or expected date on which any such reorganization,
reclassification, recapitalization, consolidation, merger, transfer, disposition, dissolution,
liquidation or winding-up is to take place, the time, if any such time is to be fixed, as of which
the holders of record of Common Stock shall be entitled to exchange their shares of Common Stock
for the shares of stock, securities or assets deliverable upon such reorganization,
reclassification, recapitalization, consolidation, merger, transfer, disposition, dissolution,
liquidation or winding-up and a description in reasonable detail of the transaction and (iii) in
case of an amendment of the Certificate of Incorporation or any registration or public offering of
Common Stock, the expected date of such event and a description in reasonable detail of the event.
Such notice shall be mailed to the extent practicable at least thirty (30), but not more than
ninety (90) days prior to the date therein specified. In the event that the Company at any time
sends any other notice to the holders of its Common Stock, it shall concurrently send a copy of
such notice to each Holder of a Warrant.




     8.2 Taking of Record.



          In the case of all dividends or other distributions by the Company to the holders of its
Common Stock with respect to which any provision of any Section hereof refers to the taking of a
record of such holders, the Company will in each such case take such a record and will take such
record as of the close of business on a Business Day.




     8.3 Closing of Transfer Books.



          The Company shall not at any time, except upon dissolution, liquidation or winding up of the
Company, close its stock transfer books or Warrant transfer books so as to result in preventing or
delaying the exercise or transfer of any Warrant.




9. TRANSFER RESTRICTIONS; LEGENDS




     9.1 Restrictions on Transfer and Entry into Shareholders Agreement and Registration Rights
Agreement.



          Concurrently with the execution and delivery of this Agreement, each Holder of an Original
Warrant is entering into and becoming a party to each of the Shareholders Agreement and the
Registration Rights Agreement, if not already a party thereto, by completing and executing a
signature page thereof. The Company shall not be obligated to register any transfer of Warrants
and no such purported transfer shall be effective unless and until the transferee has executed and
delivered a joinder agreement pursuant to which such assignee becomes a party to the Shareholders
Agreement and the Registration Rights Agreement.




     9.2 Legends.



          (a) Each Warrant Certificate shall be stamped or otherwise imprinted with a legend in
substantially the following form:





          (i) “NEITHER THE WARRANTS REPRESENTED BY THIS CERTIFICATE NOR ANY OF THE SECURITIES
ISSUABLE UPON EXERCISE



17









 







THEREOF HAVE BEEN REGISTERED PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND NEITHER THE WARRANTS REPRESENTED
BY THIS CERTIFICATE NOR ANY OF THE SECURITIES ISSUABLE UPON EXERCISE THEREOF MAY BE
TRANSFERRED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS SUCH DISPOSITION
IS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR IS MADE IN A TRANSACTION EXEMPT FROM
SUCH REGISTRATION REQUIREMENTS.”




          (ii) “THE WARRANTS REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF AN
AMENDED AND RESTATED WARRANT AGREEMENT, DATED AS OF AUGUST 27, 2009, A COPY OF WHICH IS ON
FILE WITH THE SECRETARY OF THE COMPANY.”




          (iii) “THE TRANSFER, SALE, ASSIGNMENT, PLEDGE OR OTHER DISPOSITION OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS RESTRICTED BY AND SUBJECT TO THE TERMS AND CONDITIONS
SPECIFIED IN THAT CERTAIN SECOND AMENDED AND RESTATED SECURITYHOLDERS’ AGREEMENT, DATED AS
OF AUGUST 27, 2009, AS AMENDED AND MODIFIED FROM TIME TO TIME, AMONG XSTREAM SYSTEMS, INC.
(THE “COMPANY”) AND CERTAIN SECURITYHOLDERS, AND THE COMPANY RESERVES THE RIGHT TO REFUSE
THE TRANSFER OF SUCH
SECURITIES UNTIL SUCH CONDITIONS HAVE BEEN FULFILLED WITH RESPECT TO SUCH TRANSFER. A
COPY OF SUCH SECOND AMENDED AND RESTATED SECURITYHOLDERS’ AGREEMENT SHALL BE FURNISHED BY
THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST AND WITHOUT CHARGE.”



          (b) Each certificate for shares of Warrant Stock shall be stamped or otherwise imprinted with
a legend in substantially the following form:





          (i) “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY
NOT BE TRANSFERRED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS SUCH
DISPOSITION IS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF
1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR IS MADE IN A TRANSACTION
EXEMPT FROM SUCH REGISTRATION REQUIREMENTS.”




          (ii) “THE TRANSFER, SALE, ASSIGNMENT, PLEDGE OR OTHER DISPOSITION OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS RESTRICTED BY AND SUBJECT TO THE TERMS AND CONDITIONS
SPECIFIED IN THAT CERTAIN SECOND AMENDED AND



18









 







RESTATED SECURITYHOLDERS’ AGREEMENT, DATED AS
OF AUGUST 27, 2009, AS AMENDED AND MODIFIED FROM TIME TO TIME, AMONG XSTREAM SYSTEMS, INC.
(THE “COMPANY”) AND CERTAIN SECURITYHOLDERS, AND THE COMPANY RESERVES THE RIGHT TO REFUSE
THE TRANSFER OF SUCH SECURITIES UNTIL SUCH CONDITIONS HAVE BEEN FULFILLED WITH RESPECT TO
SUCH TRANSFER. A COPY OF SUCH SECOND AMENDED AND RESTATED SECURITYHOLDERS’ AGREEMENT SHALL
BE FURNISHED BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST AND WITHOUT CHARGE.”



          (c) In addition, Warrant Certificates and any certificates for shares of Warrant Stock shall
bear any legends required by applicable state law. When any Warrants or shares of Warrant Stock
have been registered under the Securities Act, and such Warrants or shares of Warrant Stock have
been sold pursuant to such registration or pursuant to Rule 144 under the Securities Act or are
eligible to be sold pursuant to paragraph (k) of such Rule, the Holder of such Warrants or shares
of Warrant Stock shall be entitled to exchange, as the case may be, the Warrant Certificate
representing such Warrants for a Warrant Certificate, or a certificate representing such shares of
Warrant Stock for a new certificate, in each case not bearing the legend required by clause (a)(i)
or (b)(i), as the case may be, of this Section 9. If any Warrants or shares of Warrant
Stock cease to be subject to this Agreement or the Shareholders Agreement, as the case may be, the
Holder of such Warrants or Warrant Stock shall be entitled to exchange, as the case may be, the
Warrant Certificate representing such Warrants for a Warrant Certificate, or a certificate
representing such shares of Warrant Stock for a new certificate, in each case not bearing the
legend required by clauses (a)(ii), (a)(iii) or (b)(ii), as the case may be, of this Section
9. Each Holder agrees that, in addition to complying with the restrictions on
transfer set forth elsewhere in this Agreement, such Holder will not directly or indirectly
Transfer any Warrants (or solicit any offers to buy, purchase or otherwise acquire or take a pledge
of any Warrants) in violation of the Securities Act, applicable state securities or “blue sky” laws
or any rules or regulations thereunder, and such Holder will not Transfer any Warrants unless the
conditions set forth in the legend required by clause (a)(i) of this Section 9 are
satisfied.




10. LOSS OR MUTILATION




     Upon receipt by the Company from any Holder of evidence reasonably satisfactory to it of the
ownership of and the loss, theft, destruction or mutilation of a Warrant Certificate and an
indemnity reasonably satisfactory to it (it being understood that the written indemnification
agreement of or affidavit of loss of a Holder of an Original Warrant shall be a sufficient
indemnity) and, in case of mutilation, upon surrender and cancellation hereof, the Company will
execute and deliver in lieu hereof a new Warrant of like tenor to such Holder; provided, however,
in the case of mutilation, no indemnity shall be required if a Warrant Certificate in identifiable
form is surrendered to the Company for cancellation.



11. OFFICE OF THE COMPANY




     As long as any of the Warrants remain outstanding, the Company shall maintain an office or
agency, which may be the principal executive offices of the Company (the “Designated Office”),
where the Warrants may be presented for exercise, registration of transfer, division or



19









 







combination
as provided in this Agreement. Such Designated Office shall initially be the office of the Company
at 10305 102nd Terrace, Suite 101, Sebastian, Florida 32958. The Company may from time
to time change the Designated Office to another office of the Company or its agent within the
United States by notice given to all registered Holders of Warrants at least ten (10) Business Days
prior to the effective date of such change.



12. FINANCIAL AND BUSINESS INFORMATION




     12.1 Deliveries. Until the applicable Exercise Date with respect to a Warrant, the Company shall deliver to the
Holder of such Warrant one copy of each of the following items:



          (a) as soon as available but in any event within thirty (30) days after the end of each
monthly accounting period in each fiscal year (other than the third monthly accounting period in
each fiscal quarter), unaudited statements of income and cash flows of the Company for such monthly
period and for the period from the beginning of the fiscal year to the end of such month, and an
unaudited balance sheet of the Company as of the end of such monthly period, setting forth in each
case comparisons to the Company’s annual budget and to the corresponding period in the preceding
fiscal year, and all such statements shall be prepared in accordance with GAAP, subject to the
absence of footnote disclosures and to normal year-end adjustments, and shall be certified by the
Company’s Chief Financial Officer;




          (b) as soon as available but in any event within forty five (45) days after the end of each
fiscal quarter in each fiscal year (other than the fourth fiscal quarter of each fiscal
year), unaudited statements of income and cash flows of the Company for such fiscal quarter
and for the period from the beginning of the fiscal year to the end of such fiscal quarter, and an
unaudited balance sheet of the Company as of the end of such fiscal quarter, setting forth in each
case comparisons to the Company’s annual budget and to the corresponding period in the preceding
fiscal year, and all such statements shall be prepared in accordance with GAAP, subject to the
absence of footnote disclosures and to normal year-end adjustments, and shall be certified by the
Company’s Chief Financial Officer;




          (c) as soon as available but in any event within ninety (90) days after the end of each fiscal
year, audited statements of income and cash flows of the Company for such fiscal year, and an
audited balance sheet of the Company as of the end of such fiscal year prepared in accordance with
GAAP, and accompanied by, with respect to the consolidated portions of such statements, an opinion
of an independent accounting firm of recognized regional standing selected by the Board, together
with comparisons to the Company’s annual budget and to the preceding fiscal year;




          (d) accompanying the financial statements referred to in subparagraphs (b) and (c), an
officer’s certificate stating that there is no event in existence that, with notice or the passage
of time or both, might become an Event of Noncompliance (as defined in the Series B Certificate of
Designation) or, if any such event exists, specifying the nature and period of existence thereof
and what actions the Company has taken or has proposed to take with respect thereto;




20









 








          (e) promptly upon receipt thereof, any additional reports, management letters or other
detailed information concerning significant aspects of the Company’s operations or financial
affairs given to the Company by its independent accountants (and not otherwise contained in other
materials provided hereunder); and




          (f) within 10 days after transmission thereof, copies of all financial statements, proxy
statements, reports and any other general written communications that the Company sends to its
stockholders and copies of all press releases and other statements made available generally by the
Company to the public concerning material developments in the Company’s business and not otherwise
posted on the Company’s external website;



provided that any Holder shall be entitled to provide notice to the Company that it elects not to
receive copies of the financial statements and other documentation referred to in this Section
12.1(a); and provided, further, that the Company shall be entitled to satisfy its obligations
under this Section 12.1(a) through electronic delivery of the financial statements and
other documentation referred to in this Section 12.1(a) or by making such information
available through a password-protected website.




     12.2 Financial Statements. Each of the financial statements referred to in Sections 12.1(a),
12.1(b) and 12.1(c) shall fairly present in all material respects the financial
condition of the Company as of the dates and for the periods stated therein, subject in the case of
the unaudited financial statements to
changes resulting from normal year-end adjustments (none of which would, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect).



13. REPRESENTATIONS AND WARRANTIES




     13.1 Holders.



          Each Holder, by its acceptance of a Warrant, represents that (i) it is an “accredited
investor,” as that term is defined in Rule 501(a) of Regulation D promulgated under the Securities
Act, (ii) it is acquiring such Warrant for its own account, not as a nominee or agent, with the
present intention of holding it for purposes of investment, and that it has no present intention of
selling it in a public distribution in violation of the federal securities laws or any applicable
state securities laws, provided that nothing contained herein shall prevent such Holder from
transferring such Warrant in compliance with the provisions of Section 4.1, and (iii) it
understands that the Warrant has not been registered under the Securities Act, or applicable state
securities laws, and is being issued in reliance on exemptions from such registration requirements
and that, as a result, the Warrant may not be re-offered or resold except in compliance with
Section 9.




     13.2 Company.



          The Company has full legal right, power and authority to enter into and perform this Agreement
and to issue the Warrants and to perform all its obligations relating thereto. The execution and
delivery of this Agreement, the issuance of the Warrants by the Company and the consummation of the
transactions contemplated hereby and thereby have all been duly authorized by the Board of the
Company and, where required, the stockholders of the Company.



21









 






No consent, waiver or authorization
of, or filing with any other Person is required in connection with any of the foregoing or with the
validity or enforceability against the Company of this Agreement or the Warrants. This Agreement
has been duly executed and delivered by the Company and constitutes the legal, valid and binding
obligation of the Company, enforceable in accordance with its terms, except as may be limited by
bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally and
subject to general principles of equity. The execution, delivery and performance of this Agreement
and the Warrants and the consummation of the transactions contemplated hereby and thereby do not
and will not, with or without the passage of time or the giving of notice or both, (i) violate any
provision of the Company’s Certificate of Incorporation or By-laws or (ii) violate any requirement
of law or any material agreement to which the Company is a party. The Warrants have been duly
executed and delivered by the Company, have been duly authorized and validly issued free and clear
of all liens, encumbrances, equities and claims, are fully paid and non-assessable, and constitutes
the legal, valid and binding obligations of the Company, enforceable in accordance with their
terms, except as may be limited by bankruptcy, insolvency, reorganization or similar laws affecting
creditors’ rights generally and subject to general principles of equity.




14. MISCELLANEOUS



     14.1 Nonwaiver.



          No course of dealing or any delay or failure to exercise any right hereunder on the part of
the Company or the Holders shall operate as a waiver of such right or otherwise prejudice the
rights, powers or remedies of such Person.




     14.2 Notice Generally.



          Any notice, demand, request, consent, approval, declaration, delivery or communication
hereunder to be made pursuant to the provisions of this Agreement shall be sufficiently given or
made if in writing and either delivered in person with receipt acknowledged or sent by registered
or certified mail, return receipt requested, postage prepaid, addressed as follows:





          (i) if to any Holder of Warrants, at its last known address appearing on the books of
the Company maintained for such purpose;




          (ii) if to the Company, at its Designated Office;


or at such other address as may be substituted by notice given as herein provided. The giving of
any notice required hereunder may be waived in writing by the party entitled to receive such
notice. Every notice, demand, request, consent, approval, declaration, delivery or other
communication hereunder shall be deemed to have been duly given or served on the date on which
personally delivered, with receipt acknowledged, or three (3) Business Days after the same shall
have been deposited in the United States mail, or one (1) Business Day after the same shall have
been delivered to Federal Express or another overnight courier service.




22









 








     14.3 Indemnification.



          If the Company fails to make, when due, any payments provided for in this Agreement, the
Company shall pay to the applicable Holder (a) interest at the Agreed Rate on any amounts due and
owing to such Holder and (b) such further amounts as shall be sufficient to cover any costs and
expenses including reasonable attorneys’ fees and expenses incurred by such Holder in collecting
any amounts due hereunder. The Company shall indemnify, save and hold harmless the Holders from
and against any and all liability, loss, cost, damage, reasonable attorneys’ and accountants’ fees
and expenses, court costs and all other out-of-pocket expenses incurred in connection with or
arising from a Company Default. This indemnification provision shall be in addition to the rights
of such Holder or Holders to bring an action against the Company for breach of contract based on
such Company Default.




     14.4 Limitation of Liability; No Stockholder Rights.



          No provision hereof, in the absence of affirmative action by the Holder to purchase shares of
Common Stock, and no enumeration herein of the rights or privileges of the Holders, shall give rise
to any liability or right of any such Holder to pay the Exercise Price for any Warrant Stock or any
liability or rights as a stockholder of the Company, in each case other than pursuant to an
exercise of a Warrant and in each case whether such liability is asserted by the Company or by
creditors of the Company.




     14.5 Remedies.



          Each Holder of Warrants, in addition to being entitled to exercise its rights granted by law,
including recovery of damages, shall be entitled to specific performance of its rights provided
under this Agreement. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Agreement, and hereby
agrees, in an action for specific performance, to waive the defense that a remedy at law would be
adequate.




     14.6 Successors and Assigns.



          Subject to the provisions of Sections 4.1 and 9, this Agreement and the rights
evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company
and the permitted successors and assigns of the Holders. The provisions of this Agreement are
intended to be for the benefit of all Holders from time to time of Warrants, and shall be
enforceable by any such Holder and, as provided in Section 4.1, such Holder’s permitted
assigns.




     14.7 Amendment.



          This Agreement and the Warrants may be modified or amended or the provisions hereof waived
with the written consent of the Company and the Majority Warrant Holders, provided, however, that
no such modification or amendment that would treat any Holder in a discriminatory manner may be
made without the prior written consent of such Holder.




23









 








     14.8 Severability.



          Wherever possible, each provision of this Agreement shall be interpreted in such manner as to
be effective and valid under applicable law, but if any provision of this Agreement shall be
prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provision
or the remaining provisions of this Agreement.




     14.9 Governing Law; Jurisdiction.



          In all respects, including all matters of construction, validity and performance, this
Agreement and the Warrants and the obligations arising hereunder and thereunder shall be governed
by, and construed and enforced in accordance with, the laws of the State of Florida applicable to
contracts made and performed in such state, except with respect to the validity of this Agreement
and the Warrants, the issuance of Warrant Stock upon exercise of the Warrants and the rights and
duties of the Company with respect to registration of transfer, which shall be governed by the laws
of the State of Delaware. The Company and each Warrant Holder hereby consents and agrees that the
United States District Court for the Southern District of Florida or any court of the State of
Florida located in Indian River County, Florida, shall have, except as set forth below, exclusive
jurisdiction to hear and determine any claims or disputes between the Company and a Holder of
Warrants pertaining to this Agreement or the Warrants or to any matter arising out of or relating
to this Agreement or the Warrants, provided, that it is acknowledged that any appeals from those
courts may have to be heard by a court located outside of Indian River County, Florida.




[Signature Page Follows]



24









 





          IN WITNESS WHEREOF, each of the Company and the Holders have caused this Agreement to be duly
executed on its behalf by a duly authorized officer or representative.




	 	 	 	 	 
	 	COMPANY:



XSTREAM SYSTEMS, INC.

 	 
	 	By:  	/s/ Anthony Chidoni	 
	 	 	Name:  	Anthony Chidoni	 
	 	 	Title:  	Secretary	 
	 



[Holder Signature Pages Follow]




[Signature Page to A&R Series B Warrant Agreement]




 









 





	 	 	 	 	 
	 	HOLDERS:


 	 
	 	
 	 
	 	 	 
	 	 	 



[Signature
Page to A&R Series B Warrant Agreement]




 









 




NOTE:


The following counterpart signature pages of holders of Series B Warrants that have
approved this amended and restated agreement as set forth below, are attached pursuant to the
authorization contained in the August 14, 2009 Written Consent of the Holders of a Majority of
the Securityholders approving this Amended and Restated Series B Warrant Agreement:



	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Issued and	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Outstanding 	 	 	 	 	 	Approval	 	B Shares	 	B %
	Name	 	Series B(1)	 	% of B	 	Rec’d	 	Approved	 	Achieved
	 	1.  	 	 	52 River Course Associates LLC
	 	 	58,332	 	 	 	3.60	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	2.  	 	 	Anthony Chidoni
	 	 	99,999	 	 	 	6.18	%	 	 	Y	 	 	 	99,999	 	 	 	6.18	%
	 	3.  	 	 	Arthur Calcagnini
	 	 	16,666	 	 	 	1.03	%	 	 	Y	 	 	 	16,666	 	 	 	1.03	%
	 	4.  	 	 	Arthur Mclnerney
	 	 	5,000	 	 	 	0.31	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	5.  	 	 	C.B. Rogers, Jr.
	 	 	42,003	 	 	 	2.59	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	6.  	 	 	Carole Delaire
	 	 	5,000	 	 	 	0.31	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	7.  	 	 	Dennis Cummings
	 	 	16,666	 	 	 	1.03	%	 	 	Y	 	 	 	16,666	 	 	 	1.03	%
	 	8.  	 	 	Dick Fava
	 	 	16,666	 	 	 	1.03	%	 	 	Y	 	 	 	16,666	 	 	 	1.03	%
	 	9.  	 	 	Earl Segerdahl
	 	 	16,666	 	 	 	1.03	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	10.	 	 	Entrust IRA Administration, Inc. FBO Jack Gruber
IRA 0226360TR
	 	 	67,251	 	 	 	4.15	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	11.	 	 	Feldman Partners
	 	 	5,000	 	 	 	0.31	%	 	 	Y	 	 	 	5,000	 	 	 	0.31	%
	 	12.	 	 	Frank J. Lincoln, Jr.
	 	 	33,625	 	 	 	2.08	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	13.	 	 	Geoffrey Stringer
	 	 	24,999	 	 	 	1.54	%	 	 	Y	 	 	 	24,999	 	 	 	1.54	%
	 	14.	 	 	James Bennett
	 	 	16,666	 	 	 	1.03	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	15.	 	 	James Coyne
	 	 	8,333	 	 	 	0.51	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	16.	 	 	Jane Delaire
	 	 	5,000	 	 	 	0.31	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	17.	 	 	John Edison
	 	 	16,666	 	 	 	1.03	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	18.	 	 	John M Dalton
	 	 	5,000	 	 	 	0.31	%	 	 	Y	 	 	 	5,000	 	 	 	0.31	%
	 	19.	 	 	Joseph Cornacchia
	 	 	33,332	 	 	 	2.06	%	 	 	Y	 	 	 	33,332	 	 	 	2.06	%
	 	20.	 	 	Joseph Melone
	 	 	58,332	 	 	 	3.60	%	 	 	Y	 	 	 	58,332	 	 	 	3.60	%
	 	21.	 	 	Judith M. Bracken
	 	 	16,812	 	 	 	1.04	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	22.	 	 	Linda Nelson
	 	 	12,179	 	 	 	0.75	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	23.	 	 	Lovejoy Family Limited Partnership
	 	 	100,386	 	 	 	6.20	%	 	 	Y	 	 	 	100,386	 	 	 	6.20	%
	 	24.	 	 	Lowrey Family Investments LLC
	 	 	200,001	 	 	 	12.35	%	 	 	Y	 	 	 	200,001	 	 	 	12.35	%
	 	25.	 	 	Mallie Ireland
	 	 	33,625	 	 	 	2.08	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	26.	 	 	Michael E. Catanzaro Jr.
	 	 	8,333	 	 	 	0.51	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	27.	 	 	Michael Haley Trustee, Michael Winder Haley
Revocable Trust U/A dated December 1, 2006
	 	 	50,000	 	 	 	3.09	%	 	 	Y	 	 	 	50,000	 	 	 	3.09	%
	 	28.	 	 	Michael W. Haley Revocable Trust
	 	 	33,333	 	 	 	2.06	%	 	 	Y	 	 	 	33,333	 	 	 	2.06	%
	 	29.	 	 	Phillip Odeen
	 	 	33,333	 	 	 	2.06	%	 	 	Y	 	 	 	33,333	 	 	 	2.06	%
	 	30.	 	 	Robert A. Prindiville 2006 Personal Trust
	 	 	50,437	 	 	 	3.12	%	 	 	Y	 	 	 	50,437	 	 	 	3.12	%
	 	31.	 	 	Robert Girling
	 	 	74,999	 	 	 	4.63	%	 	 	Y	 	 	 	74,999	 	 	 	4.63	%
	 	32.	 	 	Robert Kennedy
	 	 	33,387	 	 	 	2.06	%	 	 	Y	 	 	 	33,387	 	 	 	2.06	%
	 	33.	 	 	Robert M. Gibb
	 	 	16,812	 	 	 	1.04	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	34.	 	 	Robert Poden
	 	 	5,000	 	 	 	0.31	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	35.	 	 	Robert W. Bracken
	 	 	16,812	 	 	 	1.04	%	 	 	Y	 	 	 	16,812	 	 	 	1.04	%
	 	36.	 	 	Samuel B. Hayes III, Revocable Trust
	 	 	58,849	 	 	 	3.63	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	37.	 	 	Steven P. Kleopoulos
	 	 	8,360	 	 	 	0.52	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	38.	 	 	The Kathryn M. Dircks and Randy Joel Dircks
Living Trust
	 	 	8,406	 	 	 	0.52	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	39.	 	 	The Mayo Family Revocable Trust dated July 13,
2000
	 	 	46,782	 	 	 	2.89	%	 	 	Y	 	 	 	46,782	 	 	 	2.89	%
	 	40.	 	 	The Sanford Katz & Irma Katz Revocable Trust dated August 9, 2006
	 	 	8,333	 	 	 	0.51	%	 	 	 	 	 	 	0	 	 	 	 	 





 








 





	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Issued and	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Outstanding	 	 	 	 	 	Approval	 	B Shares	 	B %
	Name	 	Series B(1)	 	% of B	 	Rec’d	 	Approved	 	Achieved
	 	41.	 	 	The Survivor’s Trust of the
Lightfoot Revocable Trust 2/22/83
	 	 	8,406	 	 	 	0.52	%	 	 	Y	 	 	 	8,406	 	 	 	0.52	%
	 	42.	 	 	Thomas W. Cook
	 	 	100,519	 	 	 	6.21	%	 	 	Y	 	 	 	100,519	 	 	 	6.21	%
	 	43.	 	 	Triantafillos Parlapanides
	 	 	8,407	 	 	 	0.52	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	44.	 	 	William Jennings
	 	 	33,333	 	 	 	2.06	%	 	 	 	 	 	 	0	 	 	 	 	 
	 	45.	 	 	William Scully
	 	 	101,081	 	 	 	6.24	%	 	 	Y	 	 	 	101,081	 	 	 	6.24	%
	 	 	 	 	TOTALS:
	 	 	1,619,127	 	 	 	100.00	%	 	 	 	 	 	 	1,126,136	 	 	 	69.55	%





 



	(1)	 	Holders of Series B, C & D Preferred Stock received 5 warrants for each share of
Series B, C or D Preferred Stock





 








 





REDACTED




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 

	 	/s/ Anthony Chidoni	 	 
	 

	 	 

[Name] Anthony Chidoni
	 	 






 









 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant
Agreement, the A&R Series C Warrant Agreement, the Second
A&R Securityholders’ Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ A. B. Calcagnini	 	 
	 
	 	 

[Name] A. B. Calcagnini	 	 





 








 




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date first
above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’
Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 

	 	/s/ Dennis K. Cummings
 

[Name] Dennis K. Cummings
	 	 





 








 





REDACTED




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 

	 	/s/ Richard J. Fava	 	 
	 

	 	 

[Name] Richard J. Fava
	 	 






REDACTED




 









 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 	 	 
	 	 	/s/ William M. Feldman	 	 
	 	 	 	 	 
	 

	 	[Name]
	 	William M. Feldman	 	 
	 

	 	 	 	General Partner	 	 
	 

	 	 	 	Feldman Partners	 	 





 








 




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date first above written and
authorized its attachment as a counterpart to each of the Series D Purchase Agreement. the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholder’s Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Geoffrey L. Stringer
 

[Name] 	 	 





 








 




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ John M. Dalton	 	 
	 
	 	 

[Name] John M. Dalton	 	 





REDACTED


 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date first
above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Joseph M. Cornacchia	 	 
	 
	 	 

[Name] Joseph M. Cornacchia	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement; as appropriate.



	 	 	 	 	 
	 
	 	/s/ Joseph J. Melone	 	 
	 
	 	 

[Name] Joseph J. Melone	 	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date first
above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Walter R. Lovejoy	 	 
	 
	 	 

[Name] [ILLEGIBLE]

Mgr. Lovejoy Family Partnership	 	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as
of the date first above written and authorized its attachment as a counterpart to each of the
Series D Purchase Agreement, the Series D Warrant Agreement, the A&R Series B Warrant
Agreement, the A&R Series C Warrant Agreement, the Second A&R Securityholders’
Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ James Lowrey	 	 
	 
	 	 

[Name] James Lowrey	 	 





 








 




REDACTED


     IN
WITNESS WHEREOF, the undersigned have executed this written consent
as of the date first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series’ C
Warrant Agreement; the Second A&R Securityholders’ Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Michael Haley Rev. Trust	 	 
	 
	 	 

[Name] Michael Haley Rev. Trust	 	 





REDACTED


 








 




     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Philip Odeen
 

[Name] Philip Odeen	 	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date first
above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Robert A. Prindiville
 

[Name]	 	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’
Agreement and the A&R Registration Rights Agreement, as appropriate.



	 	 	 	 	 
	 
	 	/s/ Robert Girling	 	8-12-09
	 
	 	 

[Name] Robert Girling	 	 





 








 




REDACTED


     IN WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement the Second A&R Securityholders’ Agreement and the A&R Registration Rights Agreement, as
appropriate.



	 	 	 	 	 
	 

	 	/s/ Robert E. Kennedy
 

[Name] Robert E. Kennedy	 	 





 








 





          IN WITNESS WHEREOF, the undersigned have executed this
written consent as of the date first above written and authorized its attachment
as a counterpart to each of the Series D Purchase Agreement, the Series D
Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C Warrant
Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration
Rights Agreement, as appropriate.




	 	 	 	 	 
	 	 	 
	 	/s/
Robert Bracken
 	 
	 	[Name] Robert Bracken 	 
	 	 	 



6









 







	 	 	 	 	 



          IN WITNESS WHEREOF, the undersigned have executed this written consent as of
the date first above written and authorized its attachment as a counterpart to each of
the Series D Purchase Agreement, the Series D Warrant Agreement, the A&R Series B
Warrant Agreement, the A&R Series C Warrant Agreement, the Second A&R Securityholders’
Agreement and the A&R Registration Rights Agreement, as appropriate.




	 	 	 	 	 
	 	 	 
	 	/s/
Bryan T. Mayo, Trustee of
 	 
	 	The Mayo Family Revocable Trust
dated 7/13/00	 
	 	 	 



6









 






	 	 	 	 	 


REDACTED




          IN
WITNESS WHEREOF, the undersigned have executed this written consent as of the date
first above written and authorized its attachment as a counterpart to each of the Series D Purchase
Agreement, the Series D Warrant Agreement, the A&R Series B Warrant Agreement, the A&R Series C
Warrant Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration Rights
Agreement, as appropriate.




	 	 	 	 	 
	 	 	 
	 	John
C. Lightfoot, Trustee
 	 
	 	[Name]  	 
	 	 	 



6









 






	 	 	 	 	 



          IN WITNESS WHEREOF, the undersigned have executed this written
consent as of the date first above written and authorized its attachment as a
counterpart to each of the Series D Purchase Agreement, the Series D Warrant
Agreement, the A&R Series B Warrant Agreement, the A&R Series C Warrant
Agreement, the Second A&R Securityholders’ Agreement and the A&R Registration
Rights Agreement, as appropriate.




	 	 	 	 	 
	 	 	 
	 	/s/ Thomas Cook
 	 
	 	[Name] Thomas Cook 	 



8-12-09




6









 




REDACTED




          IN WITNESS WHEREOF, the undersigned have executed this written consent as
of the date first above written and authorized its attachment as a counterpart to
each of the Series D Purchase Agreement, the Series D Warrant Agreement, the A&R
Series B Warrant Agreement, the A&R Series C Warrant Agreement, the Second A&R
Securityholders’ Agreement and the A&R Registration Rights Agreement, as
appropriate.




	 	 	 	 	 
	 	 	 
	 	/s/
William P. Scully
 	 
	 	[Name]  	 
	 	 	 



6









 






	 	 	 	 	 



EXHIBIT A




FORM OF WARRANT 




XSTREAM SYSTEMS, INC.



Series B Warrant to Purchase Shares of

Common Stock, par value $.0001 per Share


NEITHER THE WARRANTS REPRESENTED BY THIS CERTIFICATE NOR ANY OF THE SECURITIES ISSUABLE UPON
EXERCISE THEREOF HAVE BEEN REGISTERED PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND NEITHER THE WARRANTS REPRESENTED BY THIS CERTIFICATE NOR
ANY OF THE SECURITIES ISSUABLE UPON EXERCISE THEREOF MAY BE TRANSFERRED, SOLD, PLEDGED,
HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS SUCH DISPOSITION IS PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE
SECURITIES LAWS, OR IS MADE IN A TRANSACTION EXEMPT FROM SUCH REGISTRATION REQUIREMENTS.



THE WARRANTS REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF AN AMENDED AND
RESTATED WARRANT AGREEMENT, DATED AS OF AUGUST 27, 2009, A COPY OF WHICH IS ON FILE WITH THE
SECRETARY OF THE COMPANY.



THE TRANSFER, SALE, ASSIGNMENT, PLEDGE OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE IS RESTRICTED BY AND SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED IN THAT CERTAIN
SECOND AMENDED AND RESTATED SECURITYHOLDERS’ AGREEMENT, DATED AS OF AUGUST 27, 2009, AS AMENDED AND
MODIFIED FROM TIME TO TIME, AMONG XSTREAM SYSTEMS, INC. (THE “COMPANY”) AND CERTAIN
SECURITYHOLDERS, AND THE COMPANY RESERVES THE RIGHT TO REFUSE THE TRANSFER OF SUCH SECURITIES UNTIL
SUCH CONDITIONS HAVE BEEN FULFILLED WITH RESPECT TO SUCH TRANSFER. A COPY OF SUCH SECOND AMENDED
AND RESTATED SECURITYHOLDERS’ AGREEMENT SHALL BE FURNISHED BY THE COMPANY TO THE HOLDER HEREOF UPON
WRITTEN REQUEST AND WITHOUT CHARGE.




No.___

December 19, 2007




          This Series B Warrant Certificate entitles [      
     
            
         
        ], and its permitted assigns,
to purchase from XStream Systems, Inc., a Delaware corporation (the “Company”), [___] shares
of duly authorized, validly issued, fully paid and nonassessable shares of common stock, par value
$0.0001 per share (the “Common Stock”), of the Company at the purchase price per share of $3.00
(subject to adjustment as provided in Section 5 of the hereinafter defined Warrant






 









 







Agreement (as so adjusted, the “Exercise Price”)), at any time or from time to time prior to 5:00
P.M., New York, New York time, on December 19, 2017 (such date, the “Expiration Date”), all subject
to the terms and conditions set forth in the Amended and Restated Warrant Agreement, dated as of
August 27, 2009 (as may be amended, modified or restated from time to time, the “Warrant
Agreement”), by and among the Company and the holders from time to time of the Warrants (the
“Holders”). The warrants represented by this Warrant Certificate are “Warrants” as defined and
provided in the Warrant Agreement and are entitled to the rights and obligations therein provided.
The Warrants may be exercised in whole or in part in the manner provided in the Warrant Agreement.
The Warrant Agreement is hereby incorporated by reference in and made a part of this Warrant
Certificate and is hereby referred to for a description of the rights, limitation of rights,
obligations, duties and immunities of the Company and the Holder.




          IN WITNESS WHEREOF, the Company has caused this Warrant Certificate to be executed and
delivered on its behalf by its duly authorized officers.




	 	 	 	 	 
	 	XSTREAM SYSTEMS, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 



 









 






	 	 	 	 	 



ANNEX A




SUBSCRIPTION FORM



[To be executed only upon exercise of Warrant]





The undersigned:




[check one]




	 	o	 	 hereby irrevocably exercises this Warrant with respect to, and hereby purchases,






	 	o	 	 in accordance with Section 3.2(e) of the Warrant Agreement,
hereby exercises this Warrant with respect to, and hereby purchases,
conditioned upon the simultaneous closing of the sale, in an offering
registered under the Securities Act or pursuant to the exercise of any
drag-along or co-sale rights under the Shareholders Agreement, of the shares
as to which this Warrant is being exercised and with the right to revoke
such exercise in the event that the closing of such sale shall not occur,




[        
                 
               ] shares of Common Stock as provided in the Warrant Agreement and herewith makes
payment of $[        
                    
            ] therefor, all at the price and on the terms and conditions specified in the
Warrant Agreement, and requests that certificates for the shares of Common Stock hereby purchased
(and any securities or other property issuable upon such exercise) be issued in the
name of and delivered to          
               
                     
               (the “Proposed Stockholder”) whose address is
          
               
             
             
         , and, if such shares of Common Stock hereby exercised do not
equal the full number of shares of Common Stock for which this Warrant Certificate is exercisable,
that a new Warrant Certificate of like tenor and date for the balance of such shares be delivered
to the undersigned.




          In connection with the exercise of this Warrant, the undersigned has provided the Company
with:





     (i) if (x) the Shareholders Agreement (as defined in the Warrant Agreement) is in
effect and will remain in effect after the issuance of the shares and (y) the Proposed
Stockholder is not already a party to the Shareholders Agreement, a joinder agreement
pursuant to which the Proposed Stockholder shall become a party to the Shareholders
Agreement and




     (ii) if (x) the Registration Rights Agreement (as defined in the Warrant Agreement) is
in effect and the shares issuable upon this exercise constitute “Registrable Securities”
(as defined in the Registration Rights Agreement) and (y) the Proposed Stockholder is not
already a party to the Registration Rights Agreement, a joinder agreement pursuant to which
the Proposed Stockholder shall become a party to the Registration Rights Agreement;



 









 




provided that the foregoing clauses (i) and (ii) shall not apply to any exercise in connection with
the exercise of any drag-along or co-sale rights under the Shareholders Agreement.




	 	 	 	 	 
	 	
 	 
	 	(Name) 	 



	 	 	 	 	 
	 	
 	 
	 	(Signature) 	 



	 	 	 	 	 
	 	
 	 
	 	(Street Address) 	 



	 	 	 	 	 
	 	
 	 
	 	(City) (State) (Zip Code) 	 




			
	NOTICE:	 	Except as otherwise contemplated by Section 4.1 of the Warrant Agreement, the signature on
this subscription must correspond with the name as written upon the face of the within Warrant
Certificate in every particular, without alteration or enlargement or any change whatsoever.











 









 








ANNEX B




ASSIGNMENT FORM



          FOR VALUE RECEIVED, the undersigned registered owner of the enclosed Warrant Certificate
hereby sells, assigns and transfers unto the Assignee named below all of the rights of the
undersigned under this Warrant Certificate, with respect to the right to purchase the number of
shares of Common Stock of the Company indicated below, and if such shares shall not include all of
the shares of Common Stock purchasable upon the exercise of Warrants represented by the enclosed
Warrant Certificate, the Company shall issue and deliver a new Warrant Certificate to the
undersigned of like tenor for such remaining shares not transferred hereunder:




					
	 	 	 	 	 
	Name and Address of Assignee
	 	Number of Shares
	 	 





and does
hereby irrevocably constitute and
appoint      
                                                       as attorney-in-fact
to register such transfer onto the books of XStream Systems, Inc. maintained for the purpose, with
full power of substitution in the premises.




          If the Assignee is not already a party to the Shareholders Agreement and the Registration
Rights Agreement (as those terms are defined in the Warrant Agreement), the undersigned registered
owner of the enclosed Warrant Certificate has provided the Company with a fully executed joinder
agreement pursuant to which the Assignee has become a party to the Shareholders Agreement and the
Registration Rights Agreement.




	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	Print Name:	 	 	 	 
	 

	 	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	Signature:	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	Witness:	 	 	 	 
	 

	 	 	 	 	 	 

	 	 







			
	NOTICE:	 	The signature on this assignment must correspond with the name as written upon the face of
the within Warrant in every particular, without alteration or enlargement or any change
whatsoever.